Biofrontera Inc.
Clinical trials sponsored by Biofrontera Inc., explained in plain language.
-
Light therapy gel shows promise for treating precancerous skin spots
Disease control OngoingThis study is testing whether a gel called Ameluz, when activated by a special red light, can safely and effectively treat actinic keratosis—rough, scaly skin patches caused by sun damage that can sometimes turn into skin cancer. About 172 adults with 4 to 15 of these spots on th…
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Light therapy trial targets common skin cancer
Disease control OngoingThis study is testing a light-based treatment called photodynamic therapy (PDT) for superficial basal cell carcinoma, a common type of skin cancer. Researchers are comparing a medicated gel (Ameluz) used with a special red light lamp to a placebo gel to see which is better at cle…
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New light treatment tested for stubborn adult acne
Disease control OngoingThis study is testing a light-based treatment for moderate to severe acne on the face. It involves applying a special gel and then shining a red light on the skin. The goal is to see if this combination is safe and works better than a placebo gel at reducing acne bumps and improv…
Phase: PHASE2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC